{"transactions":[{"id":4622520,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":183815,"kind":"person","name":"Lane Keith J.","position":1,"cik":"0002155788","reported_name":"Lane Keith J.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"EVP,  Clinical and Regulatory"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-18T01:35:25.000Z","date":"2026-09-17","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 17, 2027, and the remaining balance vests monthly on the last day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":2.67,"expiration_date":"2036-09-17","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001372514-26-000085","document":"wk-form4_1789695322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2155788/000137251426000085/wk-form4_1789695322.xml","form_type":"4"}},{"id":719442,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-07-02T20:47:12.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":911,"price":2.66,"value":2423.26,"ownership":{"direct":true},"balance_after":26064,"source":{"system":"sec-edgar","filing":"0001372514-26-000067","document":"wk-form4_1783025229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000067/wk-form4_1783025229.xml","form_type":"4"}},{"id":717460,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-02T20:46:40.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1869,"price":2.66,"value":4971.54,"ownership":{"direct":true},"balance_after":58823,"source":{"system":"sec-edgar","filing":"0001372514-26-000065","document":"wk-form4_1783025197.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000065/wk-form4_1783025197.xml","form_type":"4"}},{"id":740129,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":27207,"kind":"person","name":"Stengone Carmine N.","position":1,"cik":"0001861519","reported_name":"Stengone Carmine N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:16:21.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027."}],"balance_after":25000,"derivative":{"exercise_price":2.63,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001861519-26-000002","document":"wk-form4_1781295377.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861519/000186151926000002/wk-form4_1781295377.xml","form_type":"4"}},{"id":739356,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":1908,"kind":"person","name":"Hollander David","position":1,"cik":"0001793796","reported_name":"Hollander David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:38.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027."}],"balance_after":25000,"derivative":{"exercise_price":2.63,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001793796-26-000002","document":"wk-form4_1781295336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000179379626000002/wk-form4_1781295336.xml","form_type":"4"}},{"id":739355,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:21.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027."}],"balance_after":25000,"derivative":{"exercise_price":2.63,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001711576-26-000002","document":"wk-form4_1781295304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000171157626000002/wk-form4_1781295304.xml","form_type":"4"}},{"id":740123,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38811,"kind":"person","name":"Shapiro Aron","position":1,"cik":"0001855207","reported_name":"Shapiro Aron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T16:16:08.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027."}],"balance_after":25000,"derivative":{"exercise_price":2.63,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001855207-26-000002","document":"wk-form4_1781295365.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855207/000185520726000002/wk-form4_1781295365.xml","form_type":"4"}},{"id":740193,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T16:15:52.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027."}],"balance_after":25000,"derivative":{"exercise_price":2.63,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001895795-26-000001","document":"wk-form4_1781295350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000189579526000001/wk-form4_1781295350.xml","form_type":"4"}},{"id":739544,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T16:13:46.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on June 10, 2027."}],"balance_after":40000,"derivative":{"exercise_price":2.63,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001372514-26-000061","document":"wk-form4_1781295224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251426000061/wk-form4_1781295224.xml","form_type":"4"}},{"id":821164,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-04-02T20:47:03.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":929,"price":1.95,"value":1811.55,"ownership":{"direct":true},"balance_after":26975,"source":{"system":"sec-edgar","filing":"0001372514-26-000034","document":"wk-form4_1775162820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000034/wk-form4_1775162820.xml","form_type":"4"}},{"id":819096,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:46:14.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":929,"price":1.95,"value":1811.55,"ownership":{"direct":true},"balance_after":31741,"source":{"system":"sec-edgar","filing":"0001372514-26-000032","document":"wk-form4_1775162772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000032/wk-form4_1775162772.xml","form_type":"4"}},{"id":819095,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-04-02T20:45:32.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1906,"price":1.95,"value":3716.7,"ownership":{"direct":true},"balance_after":60692,"source":{"system":"sec-edgar","filing":"0001372514-26-000030","document":"wk-form4_1775162730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000030/wk-form4_1775162730.xml","form_type":"4"}},{"id":850467,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T20:37:12.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":13067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2027, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":13067,"derivative":{"exercise_price":1.98,"exercise_date":"2027-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":13067},"source":{"system":"sec-edgar","filing":"0001372514-26-000014","document":"wk-form4_1773175029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000014/wk-form4_1773175029.xml","form_type":"4"}},{"id":850466,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:37:12.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":6533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":32670,"source":{"system":"sec-edgar","filing":"0001372514-26-000014","document":"wk-form4_1773175029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000014/wk-form4_1773175029.xml","form_type":"4"}},{"id":850465,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T20:36:52.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":33467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2027, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":33467,"derivative":{"exercise_price":1.98,"exercise_date":"2027-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":33467},"source":{"system":"sec-edgar","filing":"0001372514-26-000013","document":"wk-form4_1773175009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000013/wk-form4_1773175009.xml","form_type":"4"}},{"id":850464,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-10T20:36:52.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":16733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":62598,"source":{"system":"sec-edgar","filing":"0001372514-26-000013","document":"wk-form4_1773175009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000013/wk-form4_1773175009.xml","form_type":"4"}},{"id":851985,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T20:36:21.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":13067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2027, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":13067,"derivative":{"exercise_price":1.98,"exercise_date":"2027-04-01","expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":13067},"source":{"system":"sec-edgar","filing":"0001372514-26-000012","document":"wk-form4_1773174978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000012/wk-form4_1773174978.xml","form_type":"4"}},{"id":851984,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-10T20:36:21.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":6533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1 , 2027, April 1 , 2028 and April 1 , 2029, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":27904,"source":{"system":"sec-edgar","filing":"0001372514-26-000012","document":"wk-form4_1773174978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251426000012/wk-form4_1773174978.xml","form_type":"4"}},{"id":855588,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-06T19:03:53.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":238,"price":2.02,"value":480.76,"ownership":{"direct":true},"balance_after":26137,"source":{"system":"sec-edgar","filing":"0001372514-26-000007","document":"wk-form4_1772823830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000007/wk-form4_1772823830.xml","form_type":"4"}},{"id":855587,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-06T19:03:29.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":238,"price":2.02,"value":480.76,"ownership":{"direct":true},"balance_after":45865,"source":{"system":"sec-edgar","filing":"0001372514-26-000006","document":"wk-form4_1772823806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000006/wk-form4_1772823806.xml","form_type":"4"}},{"id":1184742,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:29:26.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2026, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15543,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":15543},"source":{"system":"sec-edgar","filing":"0001372514-25-000036","document":"wk-form4_1743640160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251425000036/wk-form4_1743640160.xml","form_type":"4"}},{"id":1184741,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-04-03T00:29:26.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":21371,"source":{"system":"sec-edgar","filing":"0001372514-25-000036","document":"wk-form4_1743640160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251425000036/wk-form4_1743640160.xml","form_type":"4"}},{"id":1182817,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:28:59.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2026, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15543,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":15543},"source":{"system":"sec-edgar","filing":"0001372514-25-000035","document":"wk-form4_1743640133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000035/wk-form4_1743640133.xml","form_type":"4"}},{"id":1182816,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-04-03T00:28:59.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":26375,"source":{"system":"sec-edgar","filing":"0001372514-25-000035","document":"wk-form4_1743640133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000035/wk-form4_1743640133.xml","form_type":"4"}},{"id":1182819,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:28:23.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":31883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 1, 2026, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":31883,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":31883},"source":{"system":"sec-edgar","filing":"0001372514-25-000034","document":"wk-form4_1743640097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000034/wk-form4_1743640097.xml","form_type":"4"}},{"id":1182818,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-03T00:28:23.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":46103,"source":{"system":"sec-edgar","filing":"0001372514-25-000034","document":"wk-form4_1743640097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000034/wk-form4_1743640097.xml","form_type":"4"}},{"id":1182820,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":1908,"kind":"person","name":"Hollander David","position":1,"cik":"0001793796","reported_name":"Hollander David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:15:08.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026."}],"balance_after":20000,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001372514-25-000028","document":"wk-form4_1743639302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000028/wk-form4_1743639302.xml","form_type":"4"}},{"id":1183788,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":27207,"kind":"person","name":"Stengone Carmine N.","position":1,"cik":"0001861519","reported_name":"Stengone Carmine N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:11:50.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026."}],"balance_after":20000,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001372514-25-000026","document":"wk-form4_1743639103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861519/000137251425000026/wk-form4_1743639103.xml","form_type":"4"}},{"id":1182815,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T00:10:40.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026."}],"balance_after":20000,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001372514-25-000025","document":"wk-form4_1743639029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000025/wk-form4_1743639029.xml","form_type":"4"}},{"id":1183772,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38811,"kind":"person","name":"Shapiro Aron","position":1,"cik":"0001855207","reported_name":"Shapiro Aron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T20:16:32.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026."}],"balance_after":20000,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001372514-25-000030","document":"wk-form4_1743639379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855207/000137251425000030/wk-form4_1743639379.xml","form_type":"4"}},{"id":1183898,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T20:15:58.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026."}],"balance_after":20000,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001372514-25-000029","document":"wk-form4_1743639351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000137251425000029/wk-form4_1743639351.xml","form_type":"4"}},{"id":1183011,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T20:14:32.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026."}],"balance_after":30000,"derivative":{"exercise_price":2.93,"exercise_date":"2026-04-01","expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001372514-25-000027","document":"wk-form4_1743639259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251425000027/wk-form4_1743639259.xml","form_type":"4"}},{"id":1408761,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":27207,"kind":"person","name":"Stengone Carmine N.","position":1,"cik":"0001861519","reported_name":"Stengone Carmine N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-12T10:32:55.000Z","date":"2024-09-11","kind":"purchase","planned":false,"acquired":true,"shares":1250,"price":3.68,"value":4600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. The reported price of $3.68 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001372514-24-000115","document":"wk-form4_1726137169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861519/000137251424000115/wk-form4_1726137169.xml","form_type":"4"}},{"id":1409847,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38811,"kind":"person","name":"Shapiro Aron","position":1,"cik":"0001855207","reported_name":"Shapiro Aron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T07:02:13.000Z","date":"2024-09-10","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":3.6,"value":10800.0,"ownership":{"direct":false,"nature":"By The Shapiro Family Irrevocable Trust"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001372514-24-000113","document":"wk-form4_1726052526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855207/000137251424000113/wk-form4_1726052526.xml","form_type":"4"}},{"id":1427411,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T17:00:12.000Z","date":"2024-08-19","kind":"purchase","planned":false,"acquired":true,"shares":1250,"price":3.86,"value":4825.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $3.815 to $3.8798. The reported price of $3.86 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001372514-24-000111","document":"wk-form4_1724173206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000111/wk-form4_1724173206.xml","form_type":"4"}},{"id":1429116,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T15:45:36.000Z","date":"2024-08-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.96,"value":19800.0,"ownership":{"direct":true},"balance_after":5014,"source":{"system":"sec-edgar","filing":"0001372514-24-000109","document":"wk-form4_1724096730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251424000109/wk-form4_1724096730.xml","form_type":"4"}},{"id":1432918,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-08-15T20:17:41.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.21,"value":6420.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at prices ranging from $3.16 to $3.26. The reported price of $3.21 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":13599,"source":{"system":"sec-edgar","filing":"0001372514-24-000107","document":"wk-form4_1723753055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000107/wk-form4_1723753055.xml","form_type":"4"}},{"id":1459513,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:16:52.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":31259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 1, 2025, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":31259,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":31259},"source":{"system":"sec-edgar","filing":"0001372514-24-000097","document":"wk-form4_1720034205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000097/wk-form4_1720034205.xml","form_type":"4"}},{"id":1459512,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T19:16:52.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":15629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of July 1, 2025, July 1, 2026 and July 1, 2027, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":30160,"source":{"system":"sec-edgar","filing":"0001372514-24-000097","document":"wk-form4_1720034205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000097/wk-form4_1720034205.xml","form_type":"4"}},{"id":1460952,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:16:41.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":15239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 1, 2025, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15239,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":15239},"source":{"system":"sec-edgar","filing":"0001372514-24-000096","document":"wk-form4_1720034195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000096/wk-form4_1720034195.xml","form_type":"4"}},{"id":1460951,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-07-03T19:16:41.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":7620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of July 1, 2025, July 1, 2026 and July 1, 2027, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":11599,"source":{"system":"sec-edgar","filing":"0001372514-24-000096","document":"wk-form4_1720034195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000096/wk-form4_1720034195.xml","form_type":"4"}},{"id":1459511,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:16:20.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":14710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 1, 2025, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":14710,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":14710},"source":{"system":"sec-edgar","filing":"0001372514-24-000094","document":"wk-form4_1720034173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000094/wk-form4_1720034173.xml","form_type":"4"}},{"id":1459510,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-07-03T19:16:20.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":7355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of July 1, 2025, July 1, 2026 and July 1, 2027, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":18577,"source":{"system":"sec-edgar","filing":"0001372514-24-000094","document":"wk-form4_1720034173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000094/wk-form4_1720034173.xml","form_type":"4"}},{"id":1460333,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":27207,"kind":"person","name":"Stengone Carmine N.","position":1,"cik":"0001861519","reported_name":"Stengone Carmine N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:16:09.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025."}],"balance_after":1778,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0001372514-24-000093","document":"wk-form4_1720034163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861519/000137251424000093/wk-form4_1720034163.xml","form_type":"4"}},{"id":1459509,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38605,"kind":"person","name":"Walters-Hoffert Lisa","position":1,"cik":"0001711576","reported_name":"Walters-Hoffert Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:15:36.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025."}],"balance_after":1778,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0001372514-24-000090","document":"wk-form4_1720034130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000090/wk-form4_1720034130.xml","form_type":"4"}},{"id":1459508,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":1908,"kind":"person","name":"Hollander David","position":1,"cik":"0001793796","reported_name":"Hollander David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T19:15:26.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025."}],"balance_after":1778,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0001372514-24-000089","document":"wk-form4_1720034119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000089/wk-form4_1720034119.xml","form_type":"4"}},{"id":1460437,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T15:15:58.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025."}],"balance_after":1778,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0001372514-24-000092","document":"wk-form4_1720034152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000137251424000092/wk-form4_1720034152.xml","form_type":"4"}},{"id":1460324,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38811,"kind":"person","name":"Shapiro Aron","position":1,"cik":"0001855207","reported_name":"Shapiro Aron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T15:15:48.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025."}],"balance_after":1778,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0001372514-24-000091","document":"wk-form4_1720034141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855207/000137251424000091/wk-form4_1720034141.xml","form_type":"4"}},{"id":1459653,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T15:15:15.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025."}],"balance_after":1778,"derivative":{"exercise_price":4.35,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":1778},"source":{"system":"sec-edgar","filing":"0001372514-24-000088","document":"wk-form4_1720034108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251424000088/wk-form4_1720034108.xml","form_type":"4"}},{"id":1479738,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Common Stock","published_at":"2024-06-14T20:47:33.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":5.25,"value":525.0,"ownership":{"direct":true},"balance_after":3979,"source":{"system":"sec-edgar","filing":"0001372514-24-000065","document":"wk-form4_1718398034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251424000065/wk-form4_1718398034.xml","form_type":"4"}},{"id":1478640,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-06-14T19:40:23.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":1431,"price":5.29,"value":7569.99,"ownership":{"direct":true},"balance_after":11222,"source":{"system":"sec-edgar","filing":"0001372514-24-000063","document":"wk-form4_1718394015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000063/wk-form4_1718394015.xml","form_type":"4"}},{"id":1480300,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-06-13T19:49:44.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":4.999,"value":14997.0,"ownership":{"direct":true},"balance_after":14531,"source":{"system":"sec-edgar","filing":"0001372514-24-000060","document":"wk-form4_1718308174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000060/wk-form4_1718308174.xml","form_type":"4"}},{"id":1480948,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T15:51:05.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":5260,"price":4.88,"value":25668.8,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":5260,"source":{"system":"sec-edgar","filing":"0001372514-24-000061","document":"wk-form4_1718308256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000137251424000061/wk-form4_1718308256.xml","form_type":"4"}},{"id":1768797,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:49:14.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.5677,"exercise_date":"2023-09-29","expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001372514-23-000150","document":"wk-form4_1696366139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000150/wk-form4_1696366139.xml","form_type":"4"}},{"id":1768796,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Common Stock","published_at":"2023-10-03T20:49:14.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":34900,"source":{"system":"sec-edgar","filing":"0001372514-23-000150","document":"wk-form4_1696366139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000150/wk-form4_1696366139.xml","form_type":"4"}},{"id":1766716,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:48:16.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.5677,"exercise_date":"2023-09-29","expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001372514-23-000149","document":"wk-form4_1696366080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000149/wk-form4_1696366080.xml","form_type":"4"}},{"id":1766715,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:48:16.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":88338,"source":{"system":"sec-edgar","filing":"0001372514-23-000149","document":"wk-form4_1696366080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000149/wk-form4_1696366080.xml","form_type":"4"}},{"id":1766714,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:47:26.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0.5677,"exercise_date":"2023-09-29","expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001372514-23-000148","document":"wk-form4_1696366025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000148/wk-form4_1696366025.xml","form_type":"4"}},{"id":1766713,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-03T20:47:26.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":103783,"source":{"system":"sec-edgar","filing":"0001372514-23-000148","document":"wk-form4_1696366025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000148/wk-form4_1696366025.xml","form_type":"4"}},{"id":1767841,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":27207,"kind":"person","name":"Stengone Carmine N.","position":1,"cik":"0001861519","reported_name":"Stengone Carmine N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:45:28.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024."}],"balance_after":8000,"derivative":{"exercise_price":0.5677,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000145","document":"wk-form4_1696365916.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861519/000137251423000145/wk-form4_1696365916.xml","form_type":"4"}},{"id":1766712,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":1908,"kind":"person","name":"Hollander David","position":1,"cik":"0001793796","reported_name":"Hollander David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T20:44:38.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024."}],"balance_after":5000,"derivative":{"exercise_price":0.5677,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001372514-23-000144","document":"wk-form4_1696365864.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000144/wk-form4_1696365864.xml","form_type":"4"}},{"id":1767058,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T16:46:33.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024."}],"balance_after":5000,"derivative":{"exercise_price":0.5677,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001372514-23-000147","document":"wk-form4_1696365983.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251423000147/wk-form4_1696365983.xml","form_type":"4"}},{"id":1767803,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38811,"kind":"person","name":"Shapiro Aron","position":1,"cik":"0001855207","reported_name":"Shapiro Aron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T16:46:03.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024."}],"balance_after":5000,"derivative":{"exercise_price":0.5677,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001372514-23-000146","document":"wk-form4_1696365944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855207/000137251423000146/wk-form4_1696365944.xml","form_type":"4"}},{"id":1767474,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":71430,"kind":"person","name":"Gayron Kenneth L","position":1,"cik":"0001669103","reported_name":"Gayron Kenneth L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T16:44:02.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024."}],"balance_after":5000,"derivative":{"exercise_price":0.5677,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001372514-23-000143","document":"wk-form4_1696365825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669103/000137251423000143/wk-form4_1696365825.xml","form_type":"4"}},{"id":1767984,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-03T16:43:22.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024."}],"balance_after":5000,"derivative":{"exercise_price":0.5677,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001372514-23-000142","document":"wk-form4_1696365787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000137251423000142/wk-form4_1696365787.xml","form_type":"4"}},{"id":1967036,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T01:15:21.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":1600,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001372514-23-000036","document":"wf-form4_167823810655536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000036/wf-form4_167823810655536.xml","form_type":"4"}},{"id":1967035,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Finance"}}],"security":"Common Stock","published_at":"2023-03-08T01:15:21.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":7400,"source":{"system":"sec-edgar","filing":"0001372514-23-000036","document":"wf-form4_167823810655536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000137251423000036/wf-form4_167823810655536.xml","form_type":"4"}},{"id":1965227,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T01:15:04.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":10400,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":10400},"source":{"system":"sec-edgar","filing":"0001372514-23-000035","document":"wf-form4_167823809348747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000035/wf-form4_167823809348747.xml","form_type":"4"}},{"id":1965226,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-08T01:15:04.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":15600,"price":3.83,"value":59748.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":28783,"source":{"system":"sec-edgar","filing":"0001372514-23-000035","document":"wf-form4_167823809348747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000035/wf-form4_167823809348747.xml","form_type":"4"}},{"id":1965229,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T01:14:50.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":10400,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":10400},"source":{"system":"sec-edgar","filing":"0001372514-23-000034","document":"wf-form4_167823807843002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000034/wf-form4_167823807843002.xml","form_type":"4"}},{"id":1965228,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-08T01:14:50.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":25838,"source":{"system":"sec-edgar","filing":"0001372514-23-000034","document":"wf-form4_167823807843002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000034/wf-form4_167823807843002.xml","form_type":"4"}},{"id":1965225,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":1908,"kind":"person","name":"Hollander David","position":1,"cik":"0001793796","reported_name":"Hollander David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T01:13:47.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000030","document":"wf-form4_167823801678609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251423000030/wf-form4_167823801678609.xml","form_type":"4"}},{"id":1966410,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T20:15:42.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000037","document":"wf-form4_167823812887709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000137251423000037/wf-form4_167823812887709.xml","form_type":"4"}},{"id":1965849,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":71430,"kind":"person","name":"Gayron Kenneth L","position":1,"cik":"0001669103","reported_name":"Gayron Kenneth L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T20:14:36.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000033","document":"wf-form4_167823806525564.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669103/000137251423000033/wf-form4_167823806525564.xml","form_type":"4"}},{"id":1966318,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38811,"kind":"person","name":"Shapiro Aron","position":1,"cik":"0001855207","reported_name":"Shapiro Aron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T20:14:22.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000032","document":"wf-form4_167823805057575.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855207/000137251423000032/wf-form4_167823805057575.xml","form_type":"4"}},{"id":1965529,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T20:14:04.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000031","document":"wf-form4_167823803026213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000137251423000031/wf-form4_167823803026213.xml","form_type":"4"}},{"id":1965372,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T20:13:28.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000029","document":"wf-form4_167823799654732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000137251423000029/wf-form4_167823799654732.xml","form_type":"4"}},{"id":2132227,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-25T21:34:17.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.78,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-111246","document":"tm2228925-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111246/tm2228925-3_4seq1.xml","form_type":"4"}},{"id":2132226,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-10-25T21:34:17.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of October 21, 2023, October 21, 2024 and October 21, 2025, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":10238,"source":{"system":"sec-edgar","filing":"0001104659-22-111246","document":"tm2228925-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111246/tm2228925-3_4seq1.xml","form_type":"4"}},{"id":2132518,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-25T21:32:33.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 13, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":5000,"derivative":{"exercise_price":6.78,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-111243","document":"tm2228925-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000110465922111243/tm2228925-2_4seq1.xml","form_type":"4"}},{"id":2132517,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":33290,"kind":"person","name":"Tosca Melissa","position":1,"cik":"0001947184","reported_name":"Tosca Melissa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP of Finance"}}],"security":"Common Stock","published_at":"2022-10-25T21:32:33.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of September 13, 2023, September 13, 2024 and September 13, 2025, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-22-111243","document":"tm2228925-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947184/000110465922111243/tm2228925-2_4seq1.xml","form_type":"4"}},{"id":2132225,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-25T21:30:34.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":18750,"derivative":{"exercise_price":6.78,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001104659-22-111239","document":"tm2228925-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111239/tm2228925-1_4seq1.xml","form_type":"4"}},{"id":2132224,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-25T21:30:34.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on each of October 21, 2023, October 21, 2024 and October 21, 2025, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":13183,"source":{"system":"sec-edgar","filing":"0001104659-22-111239","document":"tm2228925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922111239/tm2228925-1_4seq1.xml","form_type":"4"}},{"id":2401167,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-11T21:31:07.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":108,"price":0.69,"value":74.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.70, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":22746,"source":{"system":"sec-edgar","filing":"0001104659-22-020560","document":"tm226424-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922020560/tm226424-1_4seq1.xml","form_type":"4"}},{"id":2413138,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:06:39.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":50000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-22-011498","document":"tm225348d10_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011498/tm225348d10_4.xml","form_type":"4"}},{"id":2413137,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":51688,"kind":"person","name":"Daniels Eric Joseph","position":1,"cik":"0001892943","reported_name":"Daniels Eric Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:03:48.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":25000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-011493","document":"tm225348d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011493/tm225348d4_4.xml","form_type":"4"}},{"id":2413136,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":1908,"kind":"person","name":"Hollander David","position":1,"cik":"0001793796","reported_name":"Hollander David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:02:55.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011492","document":"tm225348d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011492/tm225348d3_4.xml","form_type":"4"}},{"id":2413135,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":1908,"kind":"person","name":"Hollander David","position":1,"cik":"0001793796","reported_name":"Hollander David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:02:55.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's Board of Directors. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":4000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-22-011492","document":"tm225348d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011492/tm225348d3_4.xml","form_type":"4"}},{"id":2413134,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T00:01:37.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":75000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-22-011491","document":"tm225348d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922011491/tm225348d2_4.xml","form_type":"4"}},{"id":2413378,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38665,"kind":"person","name":"TYLE PRAVEEN","position":1,"cik":"0001296936","reported_name":"TYLE PRAVEEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:06:10.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011497","document":"tm225348d9_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296936/000110465922011497/tm225348d9_4.xml","form_type":"4"}},{"id":2413207,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:05:09.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011496","document":"tm225348d8_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000110465922011496/tm225348d8_4.xml","form_type":"4"}},{"id":2414005,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":71430,"kind":"person","name":"Gayron Kenneth L","position":1,"cik":"0001669103","reported_name":"Gayron Kenneth L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:04:51.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011495","document":"tm225348d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669103/000110465922011495/tm225348d7_4.xml","form_type":"4"}},{"id":2414432,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:04:06.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011494","document":"tm225348d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000110465922011494/tm225348d6_4.xml","form_type":"4"}},{"id":2414431,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38838,"kind":"person","name":"Parsons Erin","position":1,"cik":"0001895795","reported_name":"Parsons Erin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:04:06.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's Board of Directors. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":4000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-22-011494","document":"tm225348d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895795/000110465922011494/tm225348d6_4.xml","form_type":"4"}},{"id":2414343,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":38811,"kind":"person","name":"Shapiro Aron","position":1,"cik":"0001855207","reported_name":"Shapiro Aron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:01:11.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011490","document":"tm225348d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855207/000110465922011490/tm225348d1_4.xml","form_type":"4"}},{"id":2441107,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-06T22:10:50.000Z","date":"2022-01-05","kind":"tax_withholding","acquired":false,"shares":114,"price":1.08,"value":123.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022."}],"balance_after":22854,"source":{"system":"sec-edgar","filing":"0001104659-22-001943","document":"tm222161-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922001943/tm222161-2_4seq1.xml","form_type":"4"}},{"id":2441287,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-01-06T22:10:17.000Z","date":"2022-01-05","kind":"tax_withholding","acquired":false,"shares":326,"price":1.08,"value":352.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022."}],"balance_after":67693,"source":{"system":"sec-edgar","filing":"0001104659-22-001942","document":"tm222161-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922001942/tm222161-1_4seq1.xml","form_type":"4"}},{"id":2480263,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-12-08T21:16:32.000Z","date":"2021-12-07","kind":"tax_withholding","acquired":false,"shares":273,"price":1.3,"value":354.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2021."}],"balance_after":68019,"source":{"system":"sec-edgar","filing":"0001104659-21-147638","document":"tm2134911d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921147638/tm2134911d2_4seq1.xml","form_type":"4"}},{"id":2480262,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":26553,"kind":"person","name":"Romano Sarah","position":1,"cik":"0001697536","reported_name":"Romano Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-08T21:15:57.000Z","date":"2021-12-07","kind":"tax_withholding","acquired":false,"shares":91,"price":1.3,"value":118.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2021."}],"balance_after":22968,"source":{"system":"sec-edgar","filing":"0001104659-21-147635","document":"tm2134911d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921147635/tm2134911d1_4seq1.xml","form_type":"4"}},{"id":2500256,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":32696,"kind":"person","name":"Strem Brian M.","position":1,"cik":"0001876429","reported_name":"Strem Brian M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T21:35:41.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":17853,"price":1.41,"value":25172.73,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.41, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":27370,"source":{"system":"sec-edgar","filing":"0001104659-21-142537","document":"tm2133588-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921142537/tm2133588-1_4seq1.xml","form_type":"4"}}],"next_cursor":"2021-11-22T21:35:41.000000Z,2500256"}